Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$703K Sell
6,568
-437
-6% -$48.1K 0.01% 508
2026
Q1
$719K Buy
7,005
+207
+3% +$24.3K 0.01% 484
2025
Q4
$850K Sell
6,798
-269
-4% -$32K 0.01% 446
2025
Q3
$844K Buy
7,067
+7
+0.1% +$739 0.01% 444
2025
Q2
$650K Buy
7,060
+312
+5% +$28.5K 0.01% 482
2025
Q1
$584K Sell
6,748
-254
-4% -$25K 0.01% 498
2024
Q4
$650K Buy
7,002
+390
+6% +$37.5K 0.01% 441
2024
Q3
$604K Buy
6,612
+228
+4% +$19.1K 0.01% 446
2024
Q2
$476K Buy
6,384
+71
+1% +$5.67K 0.01% 458
2024
Q1
$541K Buy
6,313
+666
+12% +$50.9K 0.01% 442
2023
Q4
$389K Buy
5,647
+124
+2% +$7.48K 0.01% 494
2023
Q3
$306K Buy
5,523
+1,551
+39% +$88.2K 0.01% 522
2023
Q2
$221K Sell
3,972
-1
-0% -$50 ﹤0.01% 589
2023
Q1
$202K Buy
+3,973
New +$188K ﹤0.01% 595
2022
Q2
Sell
-5,188
Closed -$208K 635
2022
Q1
$208K Buy
5,188
+9
+0.2% +$428 ﹤0.01% 637
2021
Q4
$273K Hold
5,179
﹤0.01% 583
2021
Q3
$242K Sell
5,179
-200
-4% -$10.1K ﹤0.01% 596
2021
Q2
$273K Hold
5,379
0.01% 568
2021
Q1
$253K Buy
+5,379
New +$242K 0.01% 555

Other funds holding CRH

Fiduciary Trust's CRH Position: Q2 2026 in Review

Fiduciary Trust reduced its CRH (CRH) stake by 6.2% in Q2 2026, selling an estimated $48.1K and leaving 6,568 shares worth $703K. The position accounts for 0.01% of the portfolio, ranked #508.

Fiduciary Trust first reported a position in CRH in Q1 2021 and has held it in 19 quarters since. The position peaked at $850K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Fiduciary Trust held 6,568 shares of CRH worth $703K as of Q2 2026.
  • Fiduciary Trust sold 437 CRH shares in Q2 2026, an estimated $48.1K.
  • CRH made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #508 holding.
  • Fiduciary Trust first reported a position in CRH in Q1 2021 and has held it in 19 quarters since.
  • Fiduciary Trust's CRH position peaked at $850K in Q4 2025.
  • 1,031 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.